The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.
The growth of the market is driven by the factors such as, significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes. However, the market is likely to slower down its growth due to the shortage of skilled professionals.
The healthcare industry has been observing rapid transformations during the previous years. Various technological improvements have been witnessed in the segments such as, diagnosis and treatment options for chronic diseases. The increase in incidences of chronic illnesses, ageing population, are the primary factors fuelling the growth of healthcare segment.
Germany has a history of manufacturing high diagnostic imaging technologies, precision medical instruments and others. There has been an increase in the healthcare expenditure in the European countries during the previous years. As per Eurostat in 2016, healthcare expenditure in Germany was EUR 352 billion. Medical technologies is the priority of Healthcare/Life Sciences (HCT) industry. Whereas the healthcare expenditure of France was recorded as the second highest which was around EUR 257 billion, followed by the United Kingdom EUR 234 billion.
The above mentioned factors are expected to offer broad growth opportunities in the healthcare industry and this is expected to cause the demand for immunochemistry assays in the market.
Germany is expected to lead the market in the Europe region owing to the factors such as an increase in the number of cancer cases, the higher prevalence of the diseases, government initiatives, and investments for the research and development by the government bodies and private entities. Along with the government, private companies are also focusing on the development of the conditions in the country. Therefore, considering the above-mentioned factors the growth of the market in the country is likely to contribute the largest share in the Europe region during the forecast period.
Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE IMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION
By Product
Antibodies
- Primary Antibodies
- Secondary Antibodies
Equipment
- Slide Staining Systems
- Tissue Microarray Systems
- Slide Scanners
- Other Equipment
Reagents
- Histological Stains
- Blocking and Fixation Reagents
- Chromogenic Substrates
- Stabilizers
- Solvents
- Proteolytic Enzymes
Kits
By Application
Diagnostics
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
Drug Testing
By End User
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
By Geography
- Europe
- UK
- Germany
- France
- Spain
- Italy
Company Profiles
- PerkinElmer, Inc.
- Abcam Plc
- Agilent Technologies,
- Bio SB
- Bio-Rad Laboratories, Inc.
- Cell Signalling Technology, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher
- Merck KGaA
- Thermo Fisher Scientific, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application, Product, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Europe Immunochemistry Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Immunochemistry Market – Market Landscape
4.1 Overview
4.2 Market Segmentation
4.2.1 Europe Immunochemistry Market – By Product
4.2.2 Europe Immunochemistry Market – By Application
4.2.3 Europe Immunochemistry Market – By End User
4.2.4 Europe Immunochemistry Market – By Country
4.3 PEST Analysis
5. Europe Immunochemistry Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Significantly Increasing Prevalence of Cardiovascular Diseases
5.1.2 Rising Incidence of Diabetes
5.2 Key Market Restraints
5.2.1 Shortage of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Rising Healthcare Expenditure in Europe
5.4 Future Trends
5.4.1 Rising Future Conferences and Workshops
5.5 Impact Analysis
6. Immunochemistry Market – Europe Analysis
6.1 Europe Immunochemistry Market Revenue Forecasts And Analysis
6.2 Performance of Key Players
7. Europe Immunochemistry Market Analysis – By Application
7.1 Overview
7.2 Europe Immunochemistry Market, By Application, 2018 & 2027 (%)
7.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
7.3.1.1 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.4 Diagnostics
7.4.1 Overview
7.4.2 Europe Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Cancer
7.4.3.1 Overview
7.4.3.2 Europe Cancer Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Infectious Diseases
7.4.4.1 Overview
7.4.4.2 Europe Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Autoimmune Diseases
7.4.5.1 Overview
7.4.5.2 Europe Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Nephrological Diseases
7.4.6.1 Overview
7.4.6.2 Europe Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Drug Testing
7.5.1 Overview
7.5.2 Europe Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Immunochemistry Market Analysis – By Product
8.1 Overview
8.2 Europe Immunochemistry Market, By Product, 2018 & 2027 (%)
8.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.1 Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.3 Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Antibodies Market
8.4.1 Overview
8.4.2 Europe Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.3 Primary Antibodies
8.4.3.1 Overview
8.4.3.2 Europe Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4 Secondary Antibodies
8.4.4.1 Overview
8.4.4.2 Europe Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Equipment
8.5.1 Overview
8.5.2 Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.3 Slide Staining Systems
8.5.3.1 Overview
8.5.3.2 Europe Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.4 Tissue Microarrays
8.5.4.1 Overview
8.5.4.2 Europe Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.5 Slide Scanners
8.5.5.1 Overview
8.5.5.2 Europe Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.6 Other Equipment
8.5.6.1 Overview
8.5.6.2 Europe Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Reagents
8.6.1 Overview
8.6.2 Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.3 Histological Stains
8.6.3.1 Overview
8.6.3.2 Europe Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.4 Blocking & Fixation Reagents
8.6.4.1 Overview
8.6.4.2 Europe Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.5 Chromogenic Substrates
8.6.5.1 Overview
8.6.5.2 Europe Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.6 Stabilizers
8.6.6.1 Overview
8.6.6.2 Europe Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.7 Proteolytic Enzymes
8.6.7.1 Overview
8.6.7.2 Europe Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.8 Solvents
8.6.8.1 Overview
8.6.8.2 Europe Solvents Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Kits
8.7.1 Overview
8.7.2 Europe Kits Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Immunochemistry Market Analysis – By End User
9.1 Overview
9.2 Europe Immunochemistry Market, By End User, 2018 & 2027 (%)
9.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Hospital & Diagnostic Laboratories
9.4.1 Overview
9.4.2 Europe Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Institutes
9.5.1 Overview
9.5.2 Europe Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others End Users
9.6.1 Overview
9.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Europe Immunochemistry Market Revenue and Forecasts To 2027
10.1 Overview
10.1.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.2 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.2.1 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.3.1 Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.2 Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.3.3 Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.5 Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)
10.1.6 UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.1 UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.2 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.6.2.1 UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.6.3.1 UK Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.2 UK Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3.3 UK Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.4 UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.7 Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.7.2.1 Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.7.3.1 Germany Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.2 Germany Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3.3 Germany Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.4 Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.8.2.1 France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3 France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.3.1 France Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.2 France Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3.3 France Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.4 France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.9 Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.9.2.1 Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.9.3.1 Italy Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3.2 Italy Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.3.3 Italy Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.9.4 Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.10 Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.2 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.1.10.2.1 Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.10.3.1 Spain Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3.2 Spain Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.3.3 Spain Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.10.4 Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Immunochemistry Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies done by the companies in the Market, 2018 (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic developments
11.4.1 Overview
12. Immunohistochemistry Market–Key Company Profiles
12.1 Bio SB
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product portfolio
12.1.5 SWOT ANALYSIS
12.1.6 Key Developments
12.2 Cell Signaling Technology, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product portfolio
12.2.5 SWOT ANALYSIS
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PerkinElmer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abcam Plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Agilent Technologies, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Danaher
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary Of Terms
LIST OF TABLES
Table 1. Prevalence Of Diabetes In The Region, 2017. 42
Table 2. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 50
Table 3. Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 50
Table 4. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 63
Table 5. Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 63
Table 6. Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 64
Table 7. Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 64
Table 8. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 94
Table 9. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 103
Table 10. Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 104
Table 11. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 104
Table 12. Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 105
Table 13. Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 105
Table 14. Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 106
Table 15. Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 106
Table 16. UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 109
Table 17. UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 109
Table 18. UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 110
Table 19. UK Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 111
Table 20. UK Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 111
Table 21. UK Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 112
Table 22. UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 112
Table 23. Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 115
Table 24. Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 115
Table 25. Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 115
Table 26. Germany Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 116
Table 27. Germany Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 116
Table 28. Germany Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 117
Table 29. Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 117
Table 30. France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 119
Table 31. France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 120
Table 32. France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 120
Table 33. France Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 121
Table 34. France Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 121
Table 35. France Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 122
Table 36. France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 122
Table 37. Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 125
Table 38. Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 125
Table 39. Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 126
Table 40. Italy Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 126
Table 41. Italy Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 127
Table 42. Italy Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 127
Table 43. Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 128
Table 44. Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 130
Table 45. Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 131
Table 46. Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 131
Table 47. Spain Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 132
Table 48. Spain Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 132
Table 49. Spain Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 133
Table 50. Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 133
Table 1. Organic Developments Done By Companies. 135
Table 2. Inorganic developments done by Companies. 136
Table 3. Glossary Of Terms, Immunochemistry Market 175
LIST OF FIGURES
Figure 1. Europe Immunochemistry Market Overview.. 24
Figure 2. Germany is Expected To Show Remarkable Growth During The Forecast Period. 26
Figure 3. Europe Immunochemistry Market- Leading Country Markets (US$ Mn) 28
Figure 4. Immunochemistry Market Segmentation. 34
Figure 5. Europe PEST Analysis. 38
Figure 6. Immunochemistry Market Impact Analysis of Drivers & Restraints. 45
Figure 7. Europe Immunochemistry Market – Revenue Forecasts And Analysis – 2018- 2027. 47
Figure 8. Prominent Players in the Immunohistochemistry Market 48
Figure 9. Europe Immunochemistry Market, By Application, 2018 & 2027 (%) 49
Figure 10. Europe Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn) 52
Figure 11. Europe Cancer Market Revenue And Forecasts To 2027 (US$ Mn) 53
Figure 12. Europe Infectious Diseases Market Revenue And Forecasts To 2027 (US$ Mn) 55
Figure 13. Europe Autoimmune Diseases Market Revenue And Forecasts To 2027 (US$ Mn) 57
Figure 14. Europe Nephrological Diseases Market Revenue And Forecasts To 2027 (US$ Mn) 59
Figure 15. Europe Drug Testing Market Revenue And Forecasts To 2027 (US$ Mn) 60
Figure 16. Europe Immunochemistry Market, By Product 2018 & 2027 (%) 62
Figure 17. Europe Antibodies Market Revenue and Forecasts to 2027 (US$ Mn) 65
Figure 18. Europe Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn) 67
Figure 19. Europe Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn) 68
Figure 20. Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn) 70
Figure 21. Europe Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn) 72
Figure 22. Europe Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn) 74
Figure 23. Europe Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn) 75
Figure 24. Europe Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn) 77
Figure 25. Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn) 79
Figure 26. Europe Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn) 81
Figure 27. Europe Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn) 82
Figure 28. Europe Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn) 84
Figure 29. Europe Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn) 86
Figure 30. Europe Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn) 88
Figure 31. Europe Solvents Market Revenue and Forecasts to 2027 (US$ Mn) 89
Figure 32. Europe Kits Market Revenue and Forecasts to 2027 (US$ Mn) 91
Figure 33. Europe Immunochemistry Market, By End User, 2018 & 2027 (%) 93
Figure 34. Europe Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn) 96
Figure 35. Europe Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 97
Figure 36. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn) 99
Figure 37. Europe Immunohistochemistry Market Revenue Overview, by Country (2018) (US$ Mn) 101
Figure 38. Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 103
Figure 39. Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%) 107
Figure 40. UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 108
Figure 41. Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 114
Figure 42. France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 119
Figure 43. Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 124
Figure 44. Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 129
Figure 45. Growth Strategies done by the companies in the Market, 2018 (%) 134
. 175 133
The List of Companies - Europe Immunochemistry Market
- PerkinElmer, Inc.
- Abcam Plc
- Agilent Technologies,
- Bio SB
- Bio-Rad Laboratories, Inc.
- Cell Signalling Technology, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher
- Merck KGaA
- Thermo Fisher Scientific, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Immunochemistry Market
Jan 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jan 2020